Literature DB >> 16116115

Neuropsychological function in nondemented carriers of presenilin-1 mutations.

J M Ringman1, C Diaz-Olavarrieta, Y Rodriguez, M Chavez, L Fairbanks, F Paz, A Varpetian, H C Maldonado, M A Macias-Islas, J Murrell, B Ghetti, C Kawas.   

Abstract

BACKGROUND: Prospective and case-control studies have demonstrated that memory loss and executive dysfunction occur early in Alzheimer disease (AD).
OBJECTIVE: To investigate these observations by the study of persons at risk for autosomal dominant forms of AD.
METHODS: Neuropsychological and genetic tests were performed on 51 nondemented at-risk members of 10 Mexican families with two distinct presenilin-1 (PS1) mutations. Test scores were compared between PS1 mutation carriers (MCs; n = 30) and noncarriers (NCs; n = 21) by analyses of variance, co-varying for family and specific mutation. Regression analyses were performed, taking into account age relative to the median age at dementia diagnosis in the family (adjusted age), gender, Beck Depression Inventory (BDI) scores, education, and number of APOE epsilon4 alleles. Subjects were divided into age tertiles and scores compared within these groups. Composite scores for Verbal Memory, Executive Function/Working Memory, Language, and Visuospatial Function were created, and these scores compared between MCs and NCs.
RESULTS: MCs performed worse than NCs on the Mini-Mental State Examination, Trails Making Tests A and B, Delayed Recall of a 10-Word List, and Wechsler Adult Intelligence Scale WAIS Block Design. In multiple linear regression analyses, BDI score, gender, and number of APOE epsilon4 alleles did not consistently affect test scores. The differences seen between MCs and NCs were due to differences in the oldest tertile. MCs had lower Visuospatial and Executive Function/Working Memory but not Verbal Memory or Language composite scores.
CONCLUSIONS: This study is consistent with findings in sporadic Alzheimer disease of early problems with memory, visuospatial function, and particularly with executive function in PS1 mutation carriers. Depression, gender, and presence of an APOE epsilon4 allele did not demonstrate large influences on neuropsychological performance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116115      PMCID: PMC3373251          DOI: 10.1212/01.wnl.0000172919.50001.d6

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA.

Authors:  L Madisen; D I Hoar; C D Holroyd; M Crisp; M E Hodes
Journal:  Am J Med Genet       Date:  1987-06

4.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

Authors:  K Welsh; N Butters; J Hughes; R Mohs; A Heyman
Journal:  Arch Neurol       Date:  1991-03

5.  Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study.

Authors:  P Chen; G Ratcliff; S H Belle; J A Cauley; S T DeKosky; M Ganguli
Journal:  Arch Gen Psychiatry       Date:  2001-09

6.  Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia.

Authors:  D H Geschwind; J Robidoux; M Alarcón; B L Miller; K C Wilhelmsen; J L Cummings; Z S Nasreddine
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

7.  Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; F Paz; J Murrell; M Angel Macias; M Hill; C Kawas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

8.  Simple and choice reaction time in dementia: clinical implications.

Authors:  F J Pirozzolo; K J Christensen; K M Ogle; E C Hansch; W G Thompson
Journal:  Neurobiol Aging       Date:  1981       Impact factor: 4.673

9.  Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia.

Authors:  S J Duff Canning; L Leach; D Stuss; L Ngo; S E Black
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

10.  Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds.

Authors:  T D Bird; S M Sumi; E J Nemens; D Nochlin; G Schellenberg; T H Lampe; A Sadovnick; H Chui; G W Miner; J Tinklenberg
Journal:  Ann Neurol       Date:  1989-01       Impact factor: 11.274

View more
  14 in total

1.  Performance on MMSE sub-items and education level in presenilin-1 mutation carriers without dementia.

Authors:  John M Ringman; Yaneth Rodriguez; Claudia Diaz-Olavarrieta; Mireya Chavez; Michael Thompson; Lynn Fairbanks; Francisco Paz; Arousiak Varpetian; Hector Chaparro; Miguel Angel Macias-Islas; Jill Murrell; Bernardino Ghetti; Claudia Kawas
Journal:  Int Psychogeriatr       Date:  2007-04       Impact factor: 3.878

2.  The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families.

Authors:  Jill Murrell; Bernardino Ghetti; Elizabeth Cochran; Miguel Angel Macias-Islas; Luis Medina; Arousiak Varpetian; Jeffrey L Cummings; Mario F Mendez; Claudia Kawas; Helena Chui; John M Ringman
Journal:  Neurogenetics       Date:  2006-08-05       Impact factor: 2.660

3.  The neuropsychology of normal aging and preclinical Alzheimer's disease.

Authors:  Richard J Caselli; Dona E C Locke; Amylou C Dueck; David S Knopman; Bryan K Woodruff; Charlene Hoffman-Snyder; Rosa Rademakers; Adam S Fleisher; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2013-03-26       Impact factor: 21.566

4.  Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN).

Authors:  Martha Storandt; David A Balota; Andrew J Aschenbrenner; John C Morris
Journal:  Neuropsychology       Date:  2013-11-11       Impact factor: 3.295

5.  Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease.

Authors:  John M Ringman; Luis D Medina; Yaneth Rodriguez-Agudelo; Mireya Chavez; Po Lu; Jeffrey L Cummings
Journal:  Curr Alzheimer Res       Date:  2009-08       Impact factor: 3.498

Review 6.  Children of persons with Alzheimer disease: what does the future hold?

Authors:  Lissy Jarvik; Asenath LaRue; Deborah Blacker; Margaret Gatz; Claudia Kawas; John J McArdle; John C Morris; James A Mortimer; John M Ringman; Linda Ercoli; Nelson Freimer; Izabella Gokhman; Jennifer J Manly; Brenda L Plassman; Natalie Rasgon; Jeffrey Scott Roberts; Trey Sunderland; Gary E Swan; Phillip A Wolf; Alan B Zonderman
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jan-Mar       Impact factor: 2.703

Review 7.  Ushering in the study and treatment of preclinical Alzheimer disease.

Authors:  Jessica B Langbaum; Adam S Fleisher; Kewei Chen; Napatkamon Ayutyanont; Francisco Lopera; Yakeel T Quiroz; Richard J Caselli; Pierre N Tariot; Eric M Reiman
Journal:  Nat Rev Neurol       Date:  2013-06-11       Impact factor: 42.937

8.  Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review.

Authors:  David S Knopman; Richard J Caselli
Journal:  Neurodegener Dis Manag       Date:  2012

Review 9.  Genetic Insights into Alzheimer's Disease.

Authors:  Caitlin S Latimer; Katherine L Lucot; C Dirk Keene; Brenna Cholerton; Thomas J Montine
Journal:  Annu Rev Pathol       Date:  2021-01-24       Impact factor: 23.472

10.  Association of education with Aβ burden in preclinical familial and sporadic Alzheimer disease.

Authors:  Julie Gonneaud; Christophe Bedetti; Alexa Pichet Binette; Tammie L S Benzinger; John C Morris; Randall J Bateman; Judes Poirier; John C S Breitner; Sylvia Villeneuve
Journal:  Neurology       Date:  2020-08-05       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.